TOday’s Movers: SSE PLC (LON:SSE) Stock Rating Has Been Maintained by equity analysts Morgan Stanley; GBX 1650.00 Target Price Indicates 13.85% Potential

Share

SSE PLC (LON:SSE) Rating Reaffirmed

They currently have a GBX 1650.00 target price on SSE PLC (LON:SSE). The target price by Morgan Stanley would suggest a potential upside of 13.85% from the company’s stock price. This has been unveiled in recent note on Friday, 11 December.

From a total of 18 analysts covering SSE PLC (LON:SSE) stock, 8 rate it a ”Buy”, 6 a “Sell”, and 6 a ”Hold”. This means that 40% of the ratings are positive. The highest target price is GBX 1800 while the lowest target price is GBX 1225. The mean of all analyst targets is GBX 1508.94 with a 3.51% above today’s (GBX 1449.29) stock price. SSE PLC was the topic of 48 analyst reports since July 24, 2015 according to the firm StockzIntelligence Inc. Credit Suisse maintained shares on December 8 with “Neutral” rating. BNP Paribas maintained shares with “Outperform” rating and GBX 1800 target share price in a report from a November 26. AlphaValue maintained SSE stock in a recent report from December 3 with “Add” rating. Bernstein maintained the rating on November 23. Bernstein has a “Underperform” rating and a GBX 1340 price target on shares. Finally, JP Morgan maintained the stock with “Underweight” rating in a report issued on a November 26.

The stock increased 0.51% or GBX 7.29 on December 10, striking GBX 1449.29. Approximately 2.51M shares of stock traded hands or 11.56% up from the average. SSE PLC (LON:SSE) has declined 12.23% since May 14, 2015 and is downtrending. It has underperformed by 10.29% the S&P500.

TOday’s Movers: SSE PLC (LON:SSE) Stock Rating Has Been Maintained by equity analysts Morgan Stanley; GBX 1650.00 Target Price Indicates 13.85% Potential

The overall sentiment of institutions has decreased to 0.6 in Q2 2015. Its down 0.34, from 0.94 in 2015Q2. The ratio worsened, as 42 institutions have sold all the shares of SSE PLC that they owned while 51 funds have taken shares off the table. 18 funds have purchased shares for the first time while 38 added to their positions. These institutions now hold 26.36 million shares or 10.39% less than the 29.42 million shares they owned in 2015Q2.

The Fund Sterling Investment Management Inc. currently is holding shares equating to 0.38% of its total portfolio in SSE PLC representing a total of 350,771 shares. Another fund,Owl Creek Asset Management L.P., is holding a total of 2.69 million shares equating to 0.21% of their holdings. Additionally, Lucus Advisors Llc has a 207,699 share stake in SSE PLC which represents 0.16% of their total portfolio. The Fund, Tfs Capital Llc, based out of Pennsylvania, has also built up a stake in the stock, which represents a total of 0.16% of their total portfolio. Finally Tph Asset Management Llc, a fund which is based in the state of Texas reported a total holdings of 498,766 shares.

SSE plc is a United Kingdom-based company engaged in the generation, transmission, distribution and supply of electricity; in the production, storage, distribution and supply of gas, and in other energy-related services. The company has a market cap of 14.48 billion GBP. The Company’s divisions include Networks, which consists of electricity distribution, electricity transmission and gas distribution; Retail, which consists of energy supply, enterprise and energy-related services, and Wholesale, which consists of energy portfolio management and electricity generation, gas storage and gas production. It has 29.65 P/E ratio.

According to Zacks Investment Research, “Seventy Seven Energy Inc. is an oilfield services company. It is involved in drilling, hydraulic fracturing, rig relocation as well as other related services. The Company’s provides a range of well site services and equipment to the United States land-based exploration and production customers operating in unconventional resource plays. Seventy Seven Energy Inc. is based in United States.” Get a free copy of the Zacks research report on SSE PLC (SSE).

COMMENTS: